Our previous studies using nitric oxide donors as the source of ●NO have indicated that ●NO can effectively inhibit ATPase activities of P-gp and BCRP in multidrug resistant tumor cell lines, resulting in sensitization of clinically active anticancer agents [10,11]. The gene discussed is PGP; the disease is neoplasm.